logo

CHE

Chemed·NYSE
--
--(--)
--
--(--)
9.08 / 10
Outperform

Fundamental score: 9.1/10 indicating outstanding quality. Bullish factors include Cash-MV and Net income-Revenue, but headwinds are noted in Basic earnings per share (YoY growth rate %) and Diluted earnings per share (YoY growth rate %).. Overall assessment: highly favorable.

Fundamental(9.08)SentimentTechnical

Analysis Checks(2/10)

Revenue-MV
Value-0.11
Score0/3
Weight-26.18%
1M Return-2.93%
Net cash flow from operating activities per share (YoY growth rate %)
Value7.10
Score0/3
Weight-22.11%
1M Return-2.70%
Net income-Revenue
Value-0.21
Score3/3
Weight80.89%
1M Return6.40%
Basic earnings per share (YoY growth rate %)
Value-7.62
Score1/3
Weight6.36%
1M Return0.58%
Total profit (YoY growth rate %)
Value-10.38
Score1/3
Weight16.99%
1M Return1.57%
Net cash flow from operating activities (YoY growth rate %)
Value0.85
Score0/3
Weight-29.46%
1M Return-3.52%
Diluted earnings per share (YoY growth rate %)
Value-7.13
Score1/3
Weight5.88%
1M Return0.52%
Asset-MV
Value-0.50
Score1/3
Weight18.76%
1M Return1.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-10.96
Score1/3
Weight23.41%
1M Return2.16%
Cash-MV
Value-0.64
Score2/3
Weight25.46%
1M Return2.59%
Is CHE undervalued or overvalued?
  • CHE scores 9.08/10 on fundamentals and holds a Discounted valuation at present. Backed by its 17.17% ROE, 11.02% net margin, 23.31 P/E ratio, 6.04 P/B ratio, and -4.90% earnings growth, these metrics solidify its Outperform investment rating.